Compare VRDN & HSLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRDN | HSLV |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Canada |
| Employees | N/A | 51 |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2014 | N/A |
| Metric | VRDN | HSLV |
|---|---|---|
| Price | $14.18 | $6.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $35.46 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 233.1K |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | $13.73 | N/A |
| Revenue Next Year | $279.00 | $37.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.76 | $4.72 |
| 52 Week High | $34.29 | $6.77 |
| Indicator | VRDN | HSLV |
|---|---|---|
| Relative Strength Index (RSI) | 24.61 | 51.98 |
| Support Level | $13.59 | $6.15 |
| Resistance Level | $19.42 | $6.72 |
| Average True Range (ATR) | 1.00 | 0.37 |
| MACD | 0.22 | 0.02 |
| Stochastic Oscillator | 15.67 | 63.48 |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
Highlander Silver Corp. is a mineral exploration company engaged in the acquisition, exploration and evaluation of mineral properties located in Peru. It is focused on advancing the bonanza grade San Luis gold-silver project that is located in Central Peru. The company has determined that it has one operating segment, being the exploration of mineral properties.